Noven Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 83.2 | 60.7 | 52.5 |
| Cost of Goods Sold | 41.0 | 36.5 | 34.0 |
| Gross Profit | 42.1 | 24.2 | 18.5 |
| Gross Profit Margin | 50.7% | 39.8% | 35.2% |
| SG&A Expense | 146.8 | 28.7 | 27.0 |
| Depreciation & Amortization | 6.9 | 4.4 | 3.1 |
| Operating Income | (111.6) | (9.0) | (11.6) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 5.4 | 4.3 | 26.9 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (70.3) | 23.9 | 15.3 |
| Income Taxes | (24.9) | 7.9 | 5.3 |
| Net Income After Taxes | (45.4) | 16.0 | 10.0 |
| Continuing Operations | (45.4) | 16.0 | 10.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (45.4) | 16.0 | 10.0 |
| Total Net Income | (45.4) | 16.0 | 10.0 |
| Net Profit Margin | -- | 26.3% | 19.0% |
| Diluted EPS from Total Net Income ($) | (1.84) | 0.66 | 0.42 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
